Illinois to receive 83,000 doses of Johnson & Johnson vaccine by Wednesday, says IDPH
information gathered from Johns Hopkins University (by HiGeorge) and the Illinois Department of Public Health and the SSMMA COVID dashboard by Melanie Jongsma
LANSING, Ill. (March 2, 2021) – This post includes data for the village of Lansing and data visuals for the state of Illinois.
The South Suburban Mayors and Managers Association has created a COVID dashboard aggregating data from villages throughout the south suburbs. Highlights from Lansing are listed below:
- Cumulative total of COVID-19 cases: 2,990 (Previous reported total: 2,981)
- Cumulative total of COVID-19 deaths: 17 (Previous day’s total: 16)
- Seven-day positivity rate: 4.65% (reported February 27)
The graphs below are created by HiGeorge and are “live,” so they are continually updated as new data are released from official sources.
The Illinois Department of Public Health (IDPH) today reported 1,577 new confirmed and probable cases of coronavirus disease (COVID-19) in Illinois, including 47 additional deaths.
Case positivity and test positivity rate are both relevant and offer insight into the bigger COVID-19 picture. Case positivity helps us understand whether changes in the number of confirmed cases is due to more testing or due to more infections. Test positivity accounts for repeated testing and helps us understand how the virus is spreading in the population over time.
The preliminary seven-day statewide positivity for cases as a percent of total test from February 22–28, 2021, is 2.4%. The preliminary seven-day statewide test positivity from February 22–28, 2021, is 2.7%.
IDPH anticipates that the state of Illinois will receive 83,000 doses of the newly authorized Johnson & Johnson COVID-19 vaccine by Wednesday. Unlike the currently available Pfizer and Moderna doses, the Johnson & Johnson vaccine requires only one shot and can be stored at much higher temperatures. Like Pfizer and Moderna, the Johnson & Johnson vaccine is 100% effective in protecting recipients against death and hospitalization.
The vast majority of the Johnson & Johnson vaccine—more than 90%—will be distributed to mass vaccination sites throughout the state. The remaining doses will be shipped to other providers across the state.
These doses are in addition to the approximate 288,000 doses the federal government allocated to Illinois this week. This total does not include doses for the city of Chicago, which will receive its own allocation.
“As Dr. Fauci and many medical experts have pointed out time and again, we are so fortunate to have three effective vaccines that are proven to fully protect against death and hospitalization,” said IDPH Director Dr. Ngozi Ezike. “The new Johnson & Johnson vaccine will be distributed for use at mass vaccination sites across the state, so that we are maximizing their capacity and getting as many eligible Illinoisans vaccinated as possible so that we can win the race against the new virus variants and end this pandemic.”